Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD.
Enjyoji K, et al. Among authors: csizmadia e.
Nat Med. 1999 Sep;5(9):1010-7. doi: 10.1038/12447.
Nat Med. 1999.
PMID: 10470077